03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
The Ontario Court of Appeal recently released the second of two highly anticipated decisions stemmin...
Read More >
The biggest change under SECURE Act is the treatment of long-time, part-time employees under your 40...
Read More >
On December 20, 2019, the President signed legislation repealing the excise tax, otherwise known as ...
Read More >
Paul Brodie is the CEO of Brodie Consulting. He is a consultant and keynote speaker, and most intere...
Read More >
If your business is one of the 570,000 issued a No-Match Letter from the Social Security Administrat...
Read More >
The OFCCP opened the month of October by announcing three multimillion dollar settlements with major...
Read More >